<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-6-88</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-6-11-12</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Anticonvulsant Drugs</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Anticonvulsants and Serum Cholesterol</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>11</month>
<year>1992</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>6</volume>
<issue>11</issue>
<fpage>88</fpage>
<lpage>88</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1992 The Author(s)</copyright-statement>
<copyright-year>1992</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1111/j.1528-1157.1992.tb02203.x" vol="33" page="932">
<article-title>Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The effect of antiepileptic drugs (AED) on total cholesterol, high density lipoprotein (HDL) cholesterol and triglycerides was studied in 208 epileptic children compared with 175 normal children at the University of Bologna, Italy.</p>
</abstract>
<kwd-group>
<kwd>Antiepileptic Drugs</kwd>
<kwd>High Density Lipoprotein</kwd>
<kwd>Cholesterol</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The effect of antiepileptic drugs (AED) on total cholesterol, high density lipoprotein (HDL) cholesterol and triglycerides was studied in 208 epileptic children compared with 175 normal children at the University of Bologna, Italy. In epileptic patients the mean total cholesterol plasma level was higher (195 mg/dl) than that of controls (184 mg/dl). HDL cholesterol and triglyceride levels were not different in the two groups. Carbamazepine and phenobarbital treated patients had significant elevations of mean cholesterol values and valproate treated patients had a significant lowering of cholesterol. An increase in cholesterol in the primidone and phenytoin treated patients was not significant. In a group of 32 patients studied before and during AED therapy the total cholesterol level before therapy was 168 mg/dl and after therapy 203 mg/dl. The highest level (313 mg/dl) of total cholesterol was observed in a boy receiving carbamazepine therapy. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p><bold>COMMENT.</bold> Carbamazepine treated patients with a family history of hypercholesterolemia or cardiac infarction should be followed carefully for elevated levels of total cholesterol. The effect of antiepileptic drugs on cholesterol levels during treatment with the ketogenic diet should be carefully monitored, especially when treatment is combined with carbamazepine or phenobarbital.</p>
<p>Carbamazepine appeared to be responsible for a nonconvulsive status epilepticus in a 12 year old epileptic girl, in a report from Washington University School of Medicine, St. Louis, MO [<xref ref-type="bibr" rid="CIT0002">2</xref>]. CBZ level was 7.1 mcg/ml on admission. The absence status was resistant to multiple AEDs and was associated with increased intracranial pressure and transiet MRI abnormalities. CBZ should be avoided in patients with generalized, synchronous, spike-and-wave EEG patterns.</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franzoni</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Govoni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>D&#x2019;Addato</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gualandi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sangiorgi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Descovich</surname>
<given-names>GC</given-names>
</name>
<etal/>
</person-group>
<article-title>Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs</article-title>
<source>Epilepsia</source>
<year>1992</year>
<month>Sep-Oct</month>
<volume>33</volume>
<issue>5</issue>
<fpage>932</fpage>
<lpage>935</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1992.tb02203.x</pub-id>
<pub-id pub-id-type="pmid">1396438</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Callahan</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Noetzel</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities</article-title>
<source>Neurology</source>
<year>1992</year>
<month>Nov</month>
<volume>42</volume>
<issue>11</issue>
<fpage>2198</fpage>
<lpage>2201</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.42.11.2198</pub-id>
<pub-id pub-id-type="pmid">1436536</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>